FI103116B1 - Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksiInfo
- Publication number
- FI103116B1 FI103116B1 FI935064A FI935064A FI103116B1 FI 103116 B1 FI103116 B1 FI 103116B1 FI 935064 A FI935064 A FI 935064A FI 935064 A FI935064 A FI 935064A FI 103116 B1 FI103116 B1 FI 103116B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- carboxylic acid
- acid derivatives
- therapeutically useful
- novel therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93791 | 1991-05-17 | ||
| DK91937A DK93791D0 (da) | 1991-05-17 | 1991-05-17 | Nye heterocykliske carboxylsyrer |
| DK9200155 | 1992-05-14 | ||
| PCT/DK1992/000155 WO1992020658A1 (en) | 1991-05-17 | 1992-05-14 | Novel heterocyclic carboxylic acids |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI935064A FI935064A (fi) | 1993-11-16 |
| FI935064A0 FI935064A0 (fi) | 1993-11-16 |
| FI103116B FI103116B (fi) | 1999-04-30 |
| FI103116B1 true FI103116B1 (fi) | 1999-04-30 |
Family
ID=8099201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI935064A FI103116B1 (fi) | 1991-05-17 | 1993-11-16 | Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5348965A (no) |
| EP (1) | EP0585314B1 (no) |
| JP (1) | JPH06507616A (no) |
| AT (1) | ATE143009T1 (no) |
| AU (1) | AU665761B2 (no) |
| CA (1) | CA2102811A1 (no) |
| DE (1) | DE69213935T2 (no) |
| DK (2) | DK93791D0 (no) |
| ES (1) | ES2094357T3 (no) |
| FI (1) | FI103116B1 (no) |
| GR (1) | GR3021822T3 (no) |
| IL (1) | IL101887A (no) |
| NO (1) | NO300211B1 (no) |
| NZ (1) | NZ242759A (no) |
| WO (1) | WO1992020658A1 (no) |
| ZA (1) | ZA923556B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK74493D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| DK74693D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| DK74393D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| IL112223A0 (en) * | 1994-01-04 | 1995-03-30 | Novo Nordisk As | Pharmaceutical compositions for the treatment of neurological inflammatory conditions |
| US5698551A (en) * | 1995-04-07 | 1997-12-16 | Novo Nordisk A/S | Heterocyclic compounds |
| US5962449A (en) | 1995-04-07 | 1999-10-05 | Novo Nordisk A/S | Tricyclic compounds in treating hyperalgesic conditions and NIDDM |
| AU1138397A (en) * | 1995-12-15 | 1997-07-14 | Novo Nordisk A/S | Novel method |
| WO1999000376A1 (en) * | 1997-06-25 | 1999-01-07 | Novo Nordisk A/S | Novel heterocyclic compounds |
| IE970588A1 (en) | 1997-08-01 | 2000-08-23 | Elan Corp Plc | Controlled release pharmaceutical compositions containing tiagabine |
| US6468996B1 (en) * | 1998-10-21 | 2002-10-22 | Novo Nordisk A/S | Substituted hetero-polycyclic compounds as PPARα and PPARγ activators |
| CN1382441A (zh) * | 2002-05-21 | 2002-12-04 | 中国科学院上海生命科学研究院 | γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用 |
| US7417040B2 (en) * | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| US7378426B2 (en) * | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL99690C (no) * | 1956-11-15 | |||
| BE560750A (no) * | 1957-07-26 | |||
| CH368178A (de) * | 1958-09-10 | 1963-03-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen basisch substituierten heterocyclischen Verbindungen |
| DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
| FI864246A (fi) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat. |
| US4910312A (en) * | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
| DK270488D0 (da) * | 1988-05-18 | 1988-05-18 | Novo Industri As | Hidtil ukendte o-substituerede ketoximer |
-
1991
- 1991-05-17 DK DK91937A patent/DK93791D0/da not_active Application Discontinuation
-
1992
- 1992-05-14 AT AT92910899T patent/ATE143009T1/de not_active IP Right Cessation
- 1992-05-14 DE DE69213935T patent/DE69213935T2/de not_active Expired - Fee Related
- 1992-05-14 CA CA2102811A patent/CA2102811A1/en not_active Abandoned
- 1992-05-14 US US07/882,788 patent/US5348965A/en not_active Expired - Fee Related
- 1992-05-14 DK DK92910899.1T patent/DK0585314T3/da active
- 1992-05-14 ES ES92910899T patent/ES2094357T3/es not_active Expired - Lifetime
- 1992-05-14 JP JP4509775A patent/JPH06507616A/ja active Pending
- 1992-05-14 AU AU17837/92A patent/AU665761B2/en not_active Ceased
- 1992-05-14 EP EP92910899A patent/EP0585314B1/en not_active Expired - Lifetime
- 1992-05-14 WO PCT/DK1992/000155 patent/WO1992020658A1/en active IP Right Grant
- 1992-05-15 NZ NZ242759A patent/NZ242759A/en unknown
- 1992-05-15 IL IL10188792A patent/IL101887A/en not_active IP Right Cessation
- 1992-05-15 ZA ZA923556A patent/ZA923556B/xx unknown
-
1993
- 1993-11-16 FI FI935064A patent/FI103116B1/fi active
- 1993-11-17 NO NO934159A patent/NO300211B1/no not_active IP Right Cessation
-
1996
- 1996-11-28 GR GR960403213T patent/GR3021822T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0585314B1 (en) | 1996-09-18 |
| NO934159L (no) | 1993-11-17 |
| NO300211B1 (no) | 1997-04-28 |
| JPH06507616A (ja) | 1994-09-01 |
| DK93791D0 (da) | 1991-05-17 |
| DK0585314T3 (no) | 1997-05-05 |
| FI935064A (fi) | 1993-11-16 |
| FI935064A0 (fi) | 1993-11-16 |
| GR3021822T3 (en) | 1997-02-28 |
| NZ242759A (en) | 1995-03-28 |
| AU1783792A (en) | 1992-12-30 |
| ATE143009T1 (de) | 1996-10-15 |
| EP0585314A1 (en) | 1994-03-09 |
| DE69213935T2 (de) | 1997-03-27 |
| US5348965A (en) | 1994-09-20 |
| FI103116B (fi) | 1999-04-30 |
| DE69213935D1 (en) | 1996-10-24 |
| AU665761B2 (en) | 1996-01-18 |
| ES2094357T3 (es) | 1997-01-16 |
| IL101887A0 (en) | 1992-12-30 |
| WO1992020658A1 (en) | 1992-11-26 |
| ZA923556B (en) | 1993-01-27 |
| CA2102811A1 (en) | 1992-11-26 |
| NO934159D0 (no) | 1993-11-17 |
| IL101887A (en) | 1996-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA29450C2 (uk) | Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить | |
| MX9603520A (es) | Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso. | |
| HUP0100815A2 (hu) | Neurológiai és neuropszichiátriai rendellenességek kezelésére szolgáló gyógyszerkészítmények | |
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| FI103116B1 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi | |
| NO963850L (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| AU590172B2 (en) | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof | |
| ES2182975T3 (es) | Nueva quimica heterociclica. | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| BG100246A (en) | N-substituted azaheterocylic carboxylic acids and their esters | |
| GR3020575T3 (en) | New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions | |
| MX9704704A (es) | Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion. | |
| AU2287197A (en) | Heterocyclic compounds and their preparation and use | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| ES2123796T3 (es) | Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos. | |
| BG100244A (en) | N-substituted azaheterocyclic carboxylic acids and their esters | |
| MX9704621A (es) | Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion. | |
| ATE357243T1 (de) | Stoffe und zusammensetzungen für die verabreichung aktiver substanzen | |
| IT1263913B (it) | Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |